Abstract 4838: Optimization of prostate cancer organoid culture methods to grow PDX and human biopsy tissue

Abstract Backgroud: This study was aimed to develop and internally validate a nomogram for risk of upgrade of ISUP (International Society of Urology Pathology) grade group from biopsy tissue to RP (radical prostatectomy) final histology.Methods: 166 patients with prostate cancer were retrospectively analyzed and divided into two groups based on ISUP upgrade status from needle biopsy to radical prostatectomy specimen, these being the 'ISUP upgrade' group and the 'no ISUP upgrade' group. Logistic regression analysis was used to predict the significant independent factors for ISUP upgrade. A nonogram was then developed based on these independent factors, which would predict risk of ISUP upgrade. The C-index, calibration plot, and decision curve analysis were used to assess the discrimination, calibration, and clinical usefulness of the predicting model. Internal validation was evaluated by using the bootstrapping validation. Results: There were 47 patients in the ISUP upgrade group and 119 patients in the no ISUP upgrade group respectively. Patients in the ISUP upgrade group tended to be of younger age, smaller PV (prostate volume), lower GS (Gleason score) of PB (prostate biopsy) tissue than the no ISUP upgrade group (p=0.043, p=0.041, p < 0.001, p =0.04, respectively). Multivariate logistic regression analysis showed that GS ≤6 (OR=14.236, P=0.001), prostate biopsy approach (TB-SB (transperineal prostate systematic biopsy) VS TR-SB (transrectal prostate systematic biopsy), OR=0.361, P=0.03) and number of positive cores < 10 (OR=0.396, P=0.04) were the independent risk factors for ISUP upgrade. A prediction nomogram model of ISUP upgrade was built based on these significant factors above, the area under the receiver operating characteristic (AUC) curve of which was 0.802. The C-index for the prediction nomogram was 0.798 (95%CI: 0.655–0.941) and the nomogram showed good calibration. High C-index value of 0.772 could still be reached in the interval validation. Decision curve analysis also demonstrated that the threshold value of RP-ISUP upgrade risk was 3% to 67%. Conclusion: A novel nomogram incorporating PSA, GS of PCa, ways of prostate biopsy and number of positive cores was built with a relatively good accuracy to assist clinicians to evaluate the risk of ISUP upgrade in the RP specimen, especially for the low-risk prostate cancer diagnosed by TR-SB.

Download Full-text

Novel culture method to diagnose fungal infections with biopsy tissues

10.1101/2020.01.22.916346 ◽

2020 ◽

Author(s):

Jiankang Zhao ◽

Yulin Zhang ◽

Yanyan Fan ◽

Zhujia Xiong ◽

Yudi Xia ◽

...

Keyword(s):

Culture System ◽

Liquid Culture ◽

Clinical Laboratory ◽

Fungal Infections ◽

Culture Method ◽

Culture Methods ◽

Promising Alternative ◽

Biopsy Tissue ◽

Liquid Culture System ◽

Potential Pathogen

AbstractBiopsy tissue is a difficult sample to gain for the identification of potential pathogen in the clinical laboratory. At present, there are no effective culture methods for small-sized biopsy tissue. In this study, we propose a novel tissue biopsy culture method based on Myco/F lytic liquid culture system, namely, tissue was grinded before injected into culture bottles. More types and numbers of fungi are cultivated using this culture system than sputum or BALF culture. A few of mycobacteria were also detected with ground tissues. The method may be a promising alternative to or supplement for the traditional plate culture in clinical practice.

Download Full-text

Prostate cancer

10.1093/med/9780199659579.003.0064 ◽

2017 ◽

Author(s):

Matthew Cooperberg ◽

Peter Carroll

Keyword(s):

Prostate Cancer ◽

Clinical Stage ◽

Specific Antigen ◽

Mortality Rates ◽

Low Risk ◽

Gleason Grade ◽

Aggressive Treatment ◽

Careful Monitoring ◽

Biopsy Tissue

Management of prostate cancer remains controversial, in large part because of its wide heterogeneity in terms of aggressiveness and prognosis. Early detection efforts based on prostate specific antigen (PSA) and aggressive treatment of high-risk cancers have yielded major improvements in mortality rates, but overtreatment of low-risk cancers—those unlikely to cause symptoms or threaten life if they were never detected—is associated with high rates of avoidable toxicity and cost. Prostate cancer can be effectively risk-stratified based on tools (e.g. nomograms, CAPRA score) integrating the PSA level, Gleason grade, clinical stage, and extent of biopsy tissue involvement. Most men with low-risk tumours are eligible for active surveillance, a programme of careful monitoring based on PSA and follow-up biopsies. Men with higher-risk cancers are best served with radical prostatectomy or radiation therapy.

Download Full-text

Glutamine oxidation and utilization by rat and human oesophagus and duodenum

British Journal Of Nutrition ◽

10.1017/s0007114599000574 ◽

1999 ◽

Vol 81 (4) ◽

pp. 323-329 ◽

Cited By ~ 1

Author(s):

L. A. James ◽

P. G. Lunn ◽

S. Middleton ◽

M. Elia

Keyword(s):

Oxidative Metabolism ◽

Glucose Utilization ◽

Human Subjects ◽

The Other ◽

Tissue Samples ◽

Biopsy Tissue ◽

Human Biopsy

The rates of utilization and oxidation of glutamine and glucose by oesophageal and duodenal tissues have been investigated in both rats and human subjects. In the rat, glutamine utilization by oesophageal tissue was 2–3-fold lower than that in the duodenum, and this substrate contributed less than 10 % to the total oxidative metabolism of the tissue, even when glutamine was the only substrate provided. In contrast, rat duodenal tissue derived about 34 % of the total CO2 production from glutamine-C, and this contribution was not suppressed by the addition of either glucose or a mixture of the other substrates. Rates of glucose utilization and oxidation by the duodenum were lower than those for glutamine, and were significantly (P<0·001) suppressed by addition of glutamine. In both oesophageal and duodenal tissues, less than 10 % of the glutamine-C utilized was fully oxidized, approximately 60–70 % was converted to glutamate, and 30–40 % to alanine. Results obtained using human biopsy tissue samples were similar to those observed in the rat. Glutamine oxidation contributed 34 (sd 4) % of the total CO2 production by the duodenal tissue, but only 8 (sd 4) % to oesophageal tissue oxidation. The findings suggest that glutamine is not an important or preferred fuel for oesophageal tissue, whereas it is for duodenal tissue. Thus, these tissues can be expected to respond differently to glutamine administration.

Download Full-text